Who We Are​

Genomab Biotech, located at Harlem Biospace in New York City, is pioneering the development of next-generation humanized mouse models for preclinical studies, translational research, and precision medicine applications.

Our revolutionary NextVivo pharmacology platform accelerates therapeutic medicine development by providing advanced in vivo models that closely mirror the human immune system. Our flagship models offer significant advantages over traditional NSG and NOG platforms:

​

• The NVGF model features enhanced reduced host immunity, enabling superior PDX, PBMC and HSC engraftment with clearer readouts uncompromised by host immune interference

• The NVGT model uniquely develops lymph nodes - a feature absent in NOG and NSG models - allowing for more comprehensive immune response studies

 

We serve academic institutions, CROs, and pharmaceutical companies through three key offerings:

​

• Personalized CD34 humanized mice

• Custom mouse model development

• Mouse model licensing programs​

​​

Interested in advancing your research with our innovative mouse models? Contact us today to discuss how our solutions can accelerate your therapeutic development programs. Our team of experts is ready to support your specific research needs.